Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism ARFGEF inhibitors(ARFGEF family inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H29NO6 |
InChIKeyNIVPCXURXHMJGN-CIEKVUGRSA-N |
CAS Registry2756173-91-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Preclinical | CN | 12 Sep 2022 | |
Hepatocellular Carcinoma | Preclinical | GB | 12 Sep 2022 |